Polling data released Wednesday found that voters in key swing districts overwhelmingly favor candidates who are willing to directly confront Big Pharma to bring down soaring prescription drug costs.
…
Progressives, on the other hand, are throwing their weight behind a bill—led by Rep. Lloyd Doggett (D-Texas)—that would allow Medicare to negotiate lower drug prices, a proposal that is extremely popular among the U.S. public.
Under Doggett’s legislation, if drug price negotiations fail, the government would be permitted to authorize generic competition.
“Any bill that allows Pharma to engage in arbitration is inconsistent with a real effort to hold Big Pharma accountable,” Rep. Ro Khanna (D-Calif.), one of the 122 House co-sponsors of the Doggett bill, told HuffPost.
